CSBR:NASDAQ
Champions Oncology Inc
4,76 US$
arrow_downward
-1,45%(-0,070) 1K
5-noy, 16:00:00 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoCSBR tikeri uchun statistika yaratilmoqda...
Ochish
4,76 US$
Yuqori
4,85 US$
Past
4,72 US$
Bozor kapitali
66,25 mln
Oʻrtacha hajm
9,24 ming
Hajmi
9,31 ming
52 haftalik eng yuqori
8,31 US$
52 haftalik eng past
4,63 US$
Aksiya boʻyicha daromad
-0,08 US$
Beta
0,47
Muomaladagi aksiyalar
13,92 mln
Xodimlar soni
217
Ochish
4,76 US$
Yuqori
4,85 US$
Past
4,72 US$
Bozor kapitali
66,25 mln
Oʻrtacha hajm
9,24 ming
Hajmi
9,31 ming
52 haftalik eng yuqori
8,31 US$
52 haftalik eng past
4,63 US$
Aksiya boʻyicha daromad
-0,08 US$
Beta
0,47
Muomaladagi aksiyalar
13,92 mln
Xodimlar soni
217
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
The Motley Fool
·
1 soat oldin
The Nasdaq Plunges 5%. What the Data Center Crash Means for Investors
Forbes
·
50 daqiqa oldin
Hidden Risk In The SP 500: When Diversification Becomes An Illusion
Seeking Alpha
·
11 daqiqa oldin
Market Swims In A Sea Of Red
Profil
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
Champions Oncology Inc haqida
CEO-
Xodimlar soni217
Asos solingan2007
Bosh ofislarHackensack, N'yu-Jersi, Amerika Qo‘shma Shtatlari
SektorHealth Care
Industry-
Veb-saytchampionsoncology.com